XT
BEAM icon

XTX Topco’s Beam Therapeutics BEAM Stock Holding History

XTX Topco’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.24M Buy
52,061
+36,704
+239% +$1.02M 0.02% 1232
2025
Q4 		$426K Buy
+15,357
New +$392K 0.01% 1756
2024
Q4 		– Sell
-37,001
Closed -$907K – 2301
2024
Q3 		$907K Buy
37,001
+5,191
+16% +$134K 0.07% 469
2024
Q2 		$745K Buy
+31,810
New +$781K 0.06% 473
2023
Q4 		– Sell
-23,404
Closed -$563K – 1604
2023
Q3 		$563K Buy
23,404
+14,625
+167% +$392K 0.1% 331
2023
Q2 		$280K Buy
8,779
+1,517
+21% +$49.2K 0.05% 767
2023
Q1 		$222K Buy
+7,262
New +$287K 0.05% 878
2022
Q4 		– Sell
-4,524
Closed -$216K – 1133
2022
Q3 		$216K Buy
+4,524
New +$258K 0.05% 732

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

XTX Topco's BEAM Position: Q1 2026 in Review

XTX Topco increased its Beam Therapeutics (BEAM) stake by 239% in Q1 2026, buying an estimated $1.02M and bringing the position to 52,061 shares worth $1.24M. The position accounts for 0.02% of the portfolio, ranked #1232.

XTX Topco first reported a position in BEAM in Q3 2022 and has held it in 8 quarters since. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • XTX Topco held 52,061 shares of Beam Therapeutics worth $1.24M as of Q1 2026.
  • XTX Topco bought 36,704 Beam Therapeutics shares in Q1 2026, an estimated $1.02M.
  • Beam Therapeutics made up 0.02% of XTX Topco's portfolio in Q1 2026, its #1232 holding.
  • XTX Topco first reported a position in Beam Therapeutics in Q3 2022 and has held it in 8 quarters since.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.